ArticleNature communications2018

Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration.

Amine Meliani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.